SKIN MELANOMA
Clinical trials for SKIN MELANOMA explained in plain language.
Never miss a new study
Get alerted when new SKIN MELANOMA trials appear
Sign up with your email to follow new studies for SKIN MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New melanoma drug aims to match Keytruda's success
Disease control CompletedThis phase 3 trial compares a new drug, RPH-075, to the established immunotherapy Keytruda (both are forms of pembrolizumab) in people with advanced or spreading skin melanoma that cannot be surgically removed. The study aims to see if RPH-075 is as effective as Keytruda at shrin…
Matched conditions: SKIN MELANOMA
Phase: PHASE3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could a cheaper copy of keytruda work just as well against cancer?
Disease control CompletedThis study tests whether a new drug called RPH-075, a biosimilar of pembrolizumab (Keytruda), works as well as the original in people with skin melanoma, lung cancer, or head and neck cancer. Participants receive a single dose of either RPH-075 or Keytruda, and researchers compar…
Matched conditions: SKIN MELANOMA
Phase: PHASE1 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can interferon keep melanoma from coming back after surgery?
Disease control CompletedThis completed phase 2 trial tested whether adding alpha interferon to standard surgery helps prevent skin melanoma from returning. 278 participants with stage I-IV melanoma were assigned to one of six groups, including surgery alone, low or high dose interferon, chemotherapy, or…
Matched conditions: SKIN MELANOMA
Phase: PHASE2 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC